INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

The clinical impact of vascular complications as defined by VARC-1 vs. VARC-2 in patients following transcatheter aortic valve implantation

EuroIntervention 2016;12:e636-e642 published online e-edition August 2016. DOI: 10.4244/EIJV12I5A104

Kazuaki Okuyama
Kazuaki Okuyama, MD; Hasan Jilaihawi, MD; Yigal Abramowitz, MD; Mohammad Kashif, MD; Jigar Patel, MD; Heera Pokhrel, MD; Tarun Chakravarty, MD; Mamoo Nakamura, MD; Wen Cheng, MD; Raj Makkar*, MD
Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Aims: The Valve Academic Research Consortium (VARC) recommendations were devised to standardise clinical endpoint definitions which best reflect the safety and efficacy of transcatheter a

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

access sitebleedingiliac dissection/rupturetranscatheter aortic valve implantation (tavi)
Interventions for valvular diseaseTAVIVascular access and bleeding
Read next article
Early European experience with the Venus P-valve®: filling the gap in percutaneous pulmonary valve implantation

Latest news